Epidemiological methods for attributing illness

Environmental Medicine

Volumn , Issue , 2010, Pages 25-43

  Hodgson, Susan ^a   Khaw, Fu Meng ^b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b North Tyneside Primary Care Trust   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924065191     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (115)

1. Snow J. On the Mode of Communication of Cholera. London: John Churchill, 1855.
2. Semmelweis I. Die Aetiologie, der Begriff und die Prophylaxis des Kindbettfiebers [The Etiology, Concept, and Prophylaxis of Childbed Fever.] Budapest: University of Wisconsin Press, 1983.
3. Pemberton J. Will Pickles of Wensleydale. The Life of a Country Doctor. London: Geoffrey Bles, 1970.
4. Pickles WN. Epidemiology in country practice. Proc R Soc Med 1935; 28: 1337-42.
5. Doll R, Hill A. The mortality of doctors in relation to their smoking habits: A preliminary report. Br Med J 1954; 228: 1451-5.
6. Phillips R, Ball C, Sackett D et al. Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001). Available from: http://www.cebm.net/index.aspx?o=1047 (accessed January 14, 2010).
7. McBride W. Thalidomide and congenital abnormalities. Lancet 1962; 2: 1358.
8. International Programme on Chemical Safety. Guidelines on Studies in Environmental Epidemiology. Geneva: World Health Organization, 1983.
9. Mann CJ. Observational research methods. Research design II: Cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20: 54-60.
10. White A. Health Survey for England 1991. London: HMSO, 1993.
11. Bost L, Primatesta P, Dong W, Poulter N. Blood lead and blood pressure: evidence from the Health Survey for England 1995. J Hum Hyperten 1999; 13: 123-8.
12. Susser M. The logic in ecological. I: The logic of analysis. Am J Public Health 1994; 84: 825-9.
13. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-31.
14. Mazhar D, Waxman J. Dietary fat and breast cancer. QJM 2006; 99: 469-73.
15. Willett WC. Dietary fat intake and cancer risk: A controversial and instructive story. Semin Cancer Biol 1998; 8: 245-53.
16. Barash J, Johnson B, Gregorio D. Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008; 29: 212-18.
17. Tam C, Rodrigues L, O’Brien S. The study of infectious intestinal disease in England: What risk factors for presentation to general practice tell us about potential for selection bias in case-control studies of reported cases of diarrhoea. Int J Epidemiol 2003; 32: 99-105.
18. Dawber T, Meadors GE, Moore F. Epidemiological approaches to heart disease: The Framingham study. Am J Public Health 1951; 41: 279-86.
19. Friedman D, Heisey-Grove H, Argyros F et al. An outbreak of norovirus gastroenteritis associated with wedding cakes. Epidemiol Infect 2005; 133: 1057-63.
20. Maclure M. The case crossover design: A method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
21. Stafoggia M, Forastiere F, Agostini D et al. Vulnerability to heat-related mortality: A multicity, population-based, case-crossover analysis. Epidemiology 2006; 17: 315-23.
22. Warner L, Macaluso M, Austin H et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161: 765-73.
23. Francis TJ. Evaluation of the 1954 poliomyelitis vaccine field trial: Further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis. JAMA 1955; 158: 1266-70.
24. Arnold FJ, Dean H, Jay K, Knutson J. Effect of fluoridated public water supplies on dental caries prevalence. 10th year of the Grand Rapids - Muskegon study. Public Health Report 1956; 71: 652-8.
25. Lennon M. One in a million: The first community trial of water fluoridation. Bull World Health Organ 2006; 84: 759-60.
26. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [updated February 2008]. Oxford: Cochrane Collaboration, 2008.
27. Deeks JJ. Systematic reviews of published evidence: Miracles or minefields? Ann Oncol 1998; 9: 703-9.
28. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999; 28: 1-9.
29. Blair A, Burg J, Foran J et al. Guidelines for application of meta-analysis in environmental epidemiology. ISLI Risk Science Institute. Regul Toxicol Pharmacol 1995; 22: 189-97.
30. Romieu I, Berlin JA, Colditz G. Oral contraceptives and breast cancer. Review and meta-analysis. Cancer 1990; 66: 2253-63.
31. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Lancet 1996; 347: 1713-27.
32. Centers for Disease Control and Prevention. Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30: 1-3.
33. Hymes K, Greene J, Marcus A et al. Kaposi’s sarcoma in homosexual men - report of eight cases. Lancet 1981; 318: 598-600.
34. Vandenbroucke J, Pardoel V. An autopsy of epidemiologic methods: The case of “poppers” in the early epidemic of the acquired immunodeficiency syndrome (AIDS). Am J Epidemiol 1989; 129: 455-7.
35. Jaffe H, Choi K, Thomas P et al. National case-control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men. 1: Epidemiologic results. Ann Intern Med 1983; 99: 145-51.
36. Elliott P, Wartenberg D. Spatial epidemiology: Current approaches and future challenges. Environ Health Perspect 2004; 112: 998-1006.
37. International Agency for Research on Cancer. Cancer Incidence in Five Continents. Vol. 1. Berlin: Springer-Verlag, 1966.
38. Office for National Statistics. Cancer Atlas of the United Kingdom and Ireland 1991-2000. London: ONS, 2005.
39. Gardner MJ, Winter PD. Mortality in Cumberland during 1959-78 with reference to cancer in young people around Windscale. Lancet 1984; 1: 216-17.
40. McNally RJQ, Alexander FE, Bithell JF. Space-time clustering of childhood cancer in Great Britain: A national study, 1969-1993. Int J Cancer 2006; 118: 2840-6.
41. Morgenstern H. Ecologic studies. In: Rothman KJ, Greenland S (eds) Modern Epidemiology, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 1998: 459-80.
42. Forand SP, Talbot TO, Druschel C, Cross PK. Data quality and the spatial analysis of disease rates: Congenital malformations in New York State. Health Place 2002; 8: 191-9.
43. Anderson RN, Rosenberg HM. Disease classification: Measuring the effect of the Tenth Revision of the International Classification of Diseases on cause-of-death data in the United States. Stat Med 2003; 22: 1551-70.
44. Arnold R, Elliott P, Wakefield J, Quinn M. Population Counts in Small Areas: Implications for Studies of Environment and Health. Report No. 62. London: Office for National Statistics, Government Statistical Service, 1997.
45. Ward MH, Nuckols JR, Giglierano J et al. Positional accuracy of two methods of geocoding. Epidemiology 2005; 16: 542-7.
46. Openshaw S. The Modifiable Areal Unit Problem. Concepts and Techniques in Modern Geography No. 38. Norwich: Geo Books, 1984.
47. McGeehin MA, Qualters JR, Niskar AS. National environmental public health tracking program: Bridging the information gap. Environ Health Perspect 2004; 112: 1409-13.
48. Beale L, Abellan J, Hodgson S, Jarup L. Methodological issues and approaches to spatial epidemiology. Environ Health Perspect 2008; 116: 1105-10.
49. Hunter DJ. Gene-environment interactions in human diseases. Nature Rev Genet 2005; 6: 287-98.
50. Burton PR, Tobin MD, Hopper JL. Key concepts in genetic epidemiology. Lancet 2005; 366: 941-51.
51. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology. III: Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997; 19: 33-43.
52. Bell J. Predicting disease using genomics. Nature 2004; 429: 453-6.
53. Davey Smith G, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR. Genetic epidemiology and public health: Hope, hype, and future prospects. Lancet 2005; 366: 1484-98.
54. Zeger SL, Irizarry R, Peng RD. On time series analysis of public health and biomedical data. Annu Rev Public Health 2006; 27: 57-79.
55. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001; 44(Suppl. 3): B3-8.
56. McIntyre P, Leask J. Improving uptake of MMR vaccine. BMJ 2008; 336: 729-30.
57. Bell ML, Samet JM, Dominici F. Time-series studies of particulate matter. Annu Rev Public Health 2004; 25: 247-80.
58. Schwartz J. Air pollution and daily mortality: A review and meta analysis. Environ Res 1994; 64: 36-52.
59. Fouillet A, Rey G, Laurent F et al. Excess mortality related to the August 2003 heat wave in France. Int Arch Occup Environ Health 2006; 80: 16-24.
60. Johnson H, Kovats RS, McGregor G et al. The impact of the 2003 heat wave on mortality and hospital admissions in England. Health Stat Q 2005: 6-11.
61. Khuder SA, Milz S, Jordan T, Price J, Silvestri K, Butler P. The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med 2007; 45: 3-8.
62. Heidenreich WF, Bogdanova TI, Biryukov AG, Tronko ND. Time trends of thyroid cancer incidence in Ukraine after the Chernobyl accident. J Radiol Prot 2004; 24: 283-93.
63. Interdepartmental Group on Health Risks from Chemicals. Guidelines for Good Exposure Assessment Practice for Human Health Effects of Chemicals. Cranfield, Beds: Institute for Environment and Health, 2004.
64. World Health Organization. Methodology for assessment of exposure to environmental factors in application to epidemiological studies. Sci Total Environ 1995; 168: 93-100.
65. Armstrong BG. Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med 1998; 55: 651-6.
66. Nieuwenhuijsen M, Paustenbach D, Duarte-Davidson R. New developments in exposure assessment: The impact on the practice of health risk assessment and epidemiological studies. Environ Int 2006; 32: 996-1009.
67. Pless-Mulloli T, Howel D, Prince H. Prevalence of asthma and other respiratory symptoms in children living near and away from opencast coal mining sites. Int J Epidemiol 2001; 30: 556-63.
68. Logan C, O’Leary J, O’Sullivan N. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. J Virol Methods 2007; 146(1-2): 36-44.
69. Whitley E, Ball J. Statistics review 4: Sample size calculations. Crit Care 2002; 6: 335-41.
70. Florey CD. Sample size for beginners. Br Med J 1993; 306: 1181-4.
71. Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J 2003; 20: 453-8.
72. Department of Health. Research Governance Framework for Health and Social Care, 2nd edn. London: Department of Health, 2005.
73. Wacholder S, Hartge P, Lubin JH, Dosemeci M. Non-differential misclassification and bias towards the null: A clarification. Occup Environ Med. 1995; 52: 557-8.
74. Bar-Oz B, Moretti ME, Mareels G, Van Tittelboom T, Koren G. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999; 354: 1700-1.
75. Austin H, Hill HA, Flanders WD, Greenberg RS. Limitations in the application of case-control methodology. Epidemiol Rev 1994; 16: 65-76.
76. Li CY, Sung FC. A review of the healthy worker effect in occupational epidemiology. Occup Med 1999; 49: 225-9.
77. Savitz DA, Pearce N. Control selection with incomplete case ascertainment. Am J Epidemiol 1988; 127: 1109-17.
78. Kopec JA, Esdaile JM. Bias in case-control studies. A review. J Epidemiol Commun Health 1990; 44: 179-86.
79. Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: How much is too much? Eur J Epidemiol 2004; 19: 751-60.
80. Schwartz S. The fallacy of the ecological fallacy: The potential misuse of a concept and the consequences. Am J Public Health 1994; 84: 819-24.
81. Diez-Roux AV. Bringing context back into epidemiology: Variables and fallacies in multilevel analysis. Am J Public Health 1998; 88: 216-22.
82. Pearce N. The ecological fallacy strikes back. J Epidemiol Commun Health 2000; 54: 326-7.
83. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-8.
84. Blakely TA, Woodward AJ. Ecological effects in multi-level studies. J Epidemiol Commun Health 2000; 54: 367-74.
85. Diez-Roux AV, Nieto FJ, Muntaner C et al. Neighborhood environments and coronary heart disease: A multilevel analysis. Am J Epidemiol 1997; 146: 48-63.
86. Rodu B, Jansson C. Smokeless tobacco and oral cancer: A review of the risks and determinants. Crit Rev Oral Biol Med 2004; 15: 252-63.
87. MacMahon B. Concepts of multiple factors. In: Lee DH, Kotin P (eds) Multiple Factors in the Causation of Environmentally Induced Disease. New York: Academic Press, 1972.
88. Qian GS, Ross RK, Yu MC. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 3-10.
89. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829-49.
90. Anonymous. Relative or attributable risk? Lancet 1981; 2: 1211-12.
91. Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Ann Rev Public Health 2002; 23: 115-34.
92. Hirskyj P. QALY: An ethical issue that dare not speak its name. Nursing Ethics 2007; 14: 72-82.
93. Mullahy J. Live long, live well: Quantifying the health of heterogeneous populations. Health Econ 2001; 10: 429-40.
94. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-42.
95. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
96. Health Protection Agency, Health Protection Agency Scotland, National Public Health Service for Wales. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Eurosurveillance 2009; 14(22).
97. World Health Organization. Rapid Needs Assessment for Water, Sanitation and Hygiene. New Delhi: WHO, 2004.
98. Glass R, Cates WJ, Nieburg P et al. Rapid assessment of health status and preventive-medicine needs of newly arrived Kampuchean refugees, Sa Kaeo, Thailand. Lancet 1980; 315: 868-72.
99. Brimblecombe P. The Great Smog and after. In: The Big Smoke: A History of Air Pollution in London Since Medieval Times. London: Methuen, 1987: 161-78.
100. von Storch H, Costa-Cabral M, Hagner C et al. Four decades of gasoline lead emissions and control policies in Europe: A retrospective assessment. Sci Total Env 2003; 311(1-3): 151-76.
101. Millstone E, Russell J. Environmental lead and children’s intelligence. Britain must replace its lead pipes to meet WHO standards for drinking water. Br Med J 1995; 310: 1408-9.
102. Yeoh B, Woolfenden S, Wheeler D, Alperstein G, Lanphear B. Household interventions for prevention of domestic lead exposure in children. Cochrane Database of Syst Rev 2008(2): CD006047.
103. Maynard E, Thomas R, Simon D, Phipps C, Ward C, Calder I. An evaluation of recent blood lead levels in Port Pirie, South Australia. Sci Total Env 2003; 303(1-2): 25-33.
104. Howe GR, Aronson KJ, Benito E et al. The relationship between dietary fat intake and risk of colorectal cancer: Evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997; 8: 215-28.
105. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 1997; 66(6 Suppl): 1564S-71S.
106. Glass RI. New prospects for epidemiologic investigations. Science 1986; 234: 951-5.
107. Ward MH, Wartenberg D. Invited commentary: On the road to improved exposure assessment using geographic information systems. Am J Epidemiol 2006; 164: 208-11.
108. Kistemann T, Dangendorf F, Schweikart J. New perspectives on the use of geographical information systems (GIS) in environmental health sciences. Int J Hyg Environ Health 2002; 205: 169-81.
109. Nuckols JR, Ward MH, Jarup L. Using geographic information systems for exposure assessment in environmental epidemiology studies. Environ Health Perspect 2004; 112: 1007-15.
110. Elgethun K, Fenske RA, Yost MG, Palcisko GJ. Time-location analysis for exposure assessment studies of children using a novel global positioning system instrument. Environ Health Perspect 2003; 111: 115-22.
111. Herbreteau V, Salem G, Souris M, Hugot J-P, Gonzalez J-P. Thirty years of use and improvement of remote sensing, applied to epidemiology: From early promises to lasting frustration. Health Place 2007; 13: 400-3.
112. International Programme on Chemical Safety. Biomarkers and Risk Assessment: Concepts and Principles. Geneva: World Health Organization, 1993.
113. International Programme on Chemical Safety. Biomarkers in Risk Assessment: Validity and Validation. Geneva: World Health Organization, 2001.
114. Palmer LJ. UK Biobank: Bank on it. Lancet 2007; 369: 1980-2
115. Cochrane Library: www.cochrane.org